Isoplexis · pitchdeck
Isoplexis | IPO Presentation Deck | 67 slides
67 pages · 5 arc beats · 3 loops
Isoplexis | IPO Presentation Deck | 67 slides
Isoplexis · 2021-10 arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
1510152025303540455055606567
Deck intelligence map
5 coverage by narrative range · generated from this deck JSON
Narrative range 11 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits — 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides — 0/1 slides
Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 33 hits — 0/6 slides
50% 3/6 slides 33.3% 2/6 slides 100% 6/6 slides — 0/6 slides
Market Size 2 slides 100% 2/2 slides 100% 2/2 slides · 5 hits — 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides — 0/2 slides
Business Model 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits — 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides — 0/1 slides
Traction 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits — 0/1 slides
100% 1/1 slides — 0/1 slides
100% 1/1 slides — 0/1 slides
Slide inventory
67 every slide · same image gating as the playbook
06
The slide features a product image of the 'isopark' device by 'isoplex'.show_traction
Open slide detailBeat · Traction
07
The image shows the Isoplexis hardware unit with four slots for consumables, emphasizing the 'pull-through' business model.present_solution
Open slide detailBeat · Business Model
09
The slide features a presenter and a background graphic of an upward-pointing arrow, symbolizing growth.size_opportunity
Open slide detailBeat · Market Size
10
The slide features a speaker and a single key metric, likely part of a video pitch deck.summarize
13
The slide features a person speaking, likely a founder or executive, with a key metric overlaid.size_opportunity
15
The slide uses a biological process flow to explain the company's therapeutic focus areas.present_solution
17
The slide uses a growth curve to represent both historical milestones and current program volume across different disease categories.show_traction
18
The slide features a person (likely the CEO or a spokesperson) alongside the key traction metric.show_traction
23
The smoothie analogy represents a 'bulk' sample where individual components are blended together, making it impossible to isolate specific cell-level data.frame_problem
Open slide detailBeat · Problem
24
The slide uses a bowl of cells as a metaphor for a cell population, highlighting a subset of 'super charged' cells.present_solution
Open slide detailBeat · Solution
25
The slide uses a visual metaphor of cellular processes and protein interactions to explain the scope of the technology.present_solution
Open slide detailBeat · Solution
26
The slide uses a process flow diagram to show the transition from biological markers to clinical response data.present_solution
Open slide detailBeat · Solution
27
Uses a smoothie metaphor to represent bulk proteomics vs. a cell diagram for single-cell technology.frame_problem
Open slide detailBeat · Solution
28
The slide is a frame from a video presentation; the speaker is present on the right side of the frame.present_solution
Open slide detailBeat · Solution
29
The slide uses a horizontal layout to show the end-to-end workflow/product stack.present_solution
Open slide detailBeat · Solution
30
This is a frame from a video presentation; the speaker is the primary visual element.present_solution
31
The slide uses a process flow diagram to explain the technical mechanism of the product.present_solution
32
The slide is a frame from a video presentation, likely a pitch deck introduction or mission statement.inspire_vision
Open slide detailLoop · Voice Of Customer
33
The visual uses a stacked area chart style to represent market segments, though it functions more as a conceptual breakdown of the 20K SAM.size_opportunity
Open slide detailLoop · Voice Of Customer
34
The slide uses a Kaplan-Meier plot to validate the clinical utility of the CD8+ PSD biomarker.show_traction
Open slide detailLoop · Voice Of Customer
35
The slide features a speaker on the right and a list of use cases on the left.present_solution
Open slide detailLoop · Voice Of Customer
36
The slide compares PSI against other common T-cell markers, showing PSI has a P-value < 0.05 while others do not.show_traction
Open slide detailLoop · Voice Of Customer
37
The slide features a presenter on the right side, with the content on the left.present_solution
38
The chart highlights the 'Severe' category with a green box, emphasizing the predictive power of the PSI metric.show_traction
39
The slide features a presenter on the right and a list of use cases on the left.present_solution
42
The slide features a speaker alongside a key strategic objective and a supporting icon.show_traction
44
The slide features a hub-and-spoke diagram representing the platform strategy.present_solution
45
The slide uses a combination of a stacked area chart for program segments and bar charts for operational growth metrics.show_traction
Open slide detailLoop · Quick Win Big Bet
46
The central diagram shows a stacked area representation of programs across Cancer Immunology, Cell Therapy, and Inflammatory Disease.size_opportunity
Open slide detailLoop · Quick Win Big Bet
47
The slide uses a background image of a person, likely a team member or leader, to provide a human element to the data.show_traction
Open slide detailLoop · Quick Win Big Bet
48
The slide uses a list format with vertical accent bars to highlight key performance indicators and future targets.show_traction
Open slide detailLoop · Quick Win Big Bet
49
The slide uses a timeline-style arrow to show product progression and market penetration.plan_implementation
Open slide detailLoop · Quick Win Big Bet
50
The slide uses a series of icons to depict a sequential process, likely in a biotech or research context, emphasizing complexity.frame_problem
Open slide detailLoop · Cost Of Inaction
51
The slide uses a process diagram to illustrate the 'walk away' nature of the workflow.present_solution
Open slide detailLoop · Cost Of Inaction
52
The slide includes a citation to a 2016 Cancer Cell paper by Wei W et al.present_solution
Open slide detailLoop · Cost Of Inaction
53
The slide features a presenter on the right side, with the content presented as a list of value propositions on the left.present_solution
Open slide detailLoop · Cost Of Inaction
54
The slide uses a sequential process flow to explain the technical mechanism of the platform.present_solution
55
The slide uses a visual equation format (A + B -> C) to explain the company's core technological value proposition.present_solution
56
The slide uses a growth curve to visualize product expansion alongside market size increase.plan_implementation
57
The slide uses a three-column layout to categorize 153 patents across instrumentation, core sequencing/capture technologies, and specific analysis applications.cite_precedent
58
The slide features a speaker on the right and a list of four key company strengths on the left.summarize
59
The slide features a blurred background of a person, likely the CEO or presenter.show_traction
62
The slide features a speaker on the right and a list of strategic pillars on the left.present_solution
63
The slide uses a list-based structure to explain the financial drivers of the business model.present_solution
64
The slide includes a disclaimer about EBITDA being a non-GAAP measure.analyze_data
65
The slide uses stacked bar charts to show revenue composition and a table for key performance indicators.show_traction
67
The table presents financial performance metrics with audited figures for 2019-2020 and unaudited figures for H1 2021.analyze_data